Clinical trials

  • AXATILIMAB for Chronic graft versus host disease
  • Venetoclax for Multiple myeloma
  • Niraparib tosilate monohydrate for Glioblastoma (MGMT promoter unmethylated)
  • Avelumab for Urothelial carcinoma | Muscle-invasive bladder cancer
  • PEMIGATINIB for Recurrent or metastatic solid tumour with FGFR1/2/3 fusion, rearrangement or activating FGFR mutation
  • BORTEZOMIB for Relapsed acute lymphoblastic leukemia (ALL)
  • ATOGEPANT for Menstrual migraine
  • LIDOCAINE HYDROCHLORIDE for First-degree perineal laceration
  • M5542 for Healthy volunteer
  • Streptococcus agalactiae; Haemophilus influenzae; Staphylococcus aureus; Streptococcus pneumoniae for Recurrent lower respiratory tract infections
  • Sirolimus for Tuberous sclerosis complex | Epilepsy | TSC-associated tumors
  • Allogeneic skin-derived ABCB5-positive dermal mesenchymal stromal cells for Chronic venous leg ulcer